These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
351 related articles for article (PubMed ID: 12476352)
1. Fractalkine (CX3CL1) and brain inflammation: Implications for HIV-1-associated dementia. Cotter R; Williams C; Ryan L; Erichsen D; Lopez A; Peng H; Zheng J J Neurovirol; 2002 Dec; 8(6):585-98. PubMed ID: 12476352 [TBL] [Abstract][Full Text] [Related]
2. Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, during acute and chronic inflammation in the rodent CNS. Hughes PM; Botham MS; Frentzel S; Mir A; Perry VH Glia; 2002 Mar; 37(4):314-27. PubMed ID: 11870871 [TBL] [Abstract][Full Text] [Related]
3. Enhanced recruitment of CX3CR1+ T cells by mucosal endothelial cell-derived fractalkine in inflammatory bowel disease. Sans M; Danese S; de la Motte C; de Souza HS; Rivera-Reyes BM; West GA; Phillips M; Katz JA; Fiocchi C Gastroenterology; 2007 Jan; 132(1):139-53. PubMed ID: 17241867 [TBL] [Abstract][Full Text] [Related]
4. Neuronal fractalkine expression in HIV-1 encephalitis: roles for macrophage recruitment and neuroprotection in the central nervous system. Tong N; Perry SW; Zhang Q; James HJ; Guo H; Brooks A; Bal H; Kinnear SA; Fine S; Epstein LG; Dairaghi D; Schall TJ; Gendelman HE; Dewhurst S; Sharer LR; Gelbard HA J Immunol; 2000 Feb; 164(3):1333-9. PubMed ID: 10640747 [TBL] [Abstract][Full Text] [Related]
6. Transendothelial migration of CD16+ monocytes in response to fractalkine under constitutive and inflammatory conditions. Ancuta P; Moses A; Gabuzda D Immunobiology; 2004; 209(1-2):11-20. PubMed ID: 15481136 [TBL] [Abstract][Full Text] [Related]
7. Viral macrophage inflammatory protein-II and fractalkine (CX3CL1) chimeras identify molecular determinants of affinity, efficacy, and selectivity at CX3CR1. Davis CN; Zujovic V; Harrison JK Mol Pharmacol; 2004 Dec; 66(6):1431-9. PubMed ID: 15361546 [TBL] [Abstract][Full Text] [Related]
8. Expression of fractalkine and its receptor, CX3CR1, in atopic dermatitis: possible contribution to skin inflammation. Echigo T; Hasegawa M; Shimada Y; Takehara K; Sato S J Allergy Clin Immunol; 2004 May; 113(5):940-8. PubMed ID: 15131578 [TBL] [Abstract][Full Text] [Related]
9. Recruitment of CD16+ monocytes into synovial tissues is mediated by fractalkine and CX3CR1 in rheumatoid arthritis patients. Yano R; Yamamura M; Sunahori K; Takasugi K; Yamana J; Kawashima M; Makino H Acta Med Okayama; 2007 Apr; 61(2):89-98. PubMed ID: 17471309 [TBL] [Abstract][Full Text] [Related]
10. Fractalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvant-induced arthritis. Ruth JH; Volin MV; Haines GK; Woodruff DC; Katschke KJ; Woods JM; Park CC; Morel JC; Koch AE Arthritis Rheum; 2001 Jul; 44(7):1568-81. PubMed ID: 11465708 [TBL] [Abstract][Full Text] [Related]
12. Involvement of interaction between Fractalkine and CX3CR1 in cytotoxicity of natural killer cells against tumor cells. Zhang X; Wei H; Wang H; Tian Z Oncol Rep; 2006 Feb; 15(2):485-8. PubMed ID: 16391873 [TBL] [Abstract][Full Text] [Related]
13. Mice deficient in fractalkine are less susceptible to cerebral ischemia-reperfusion injury. Soriano SG; Amaravadi LS; Wang YF; Zhou H; Yu GX; Tonra JR; Fairchild-Huntress V; Fang Q; Dunmore JH; Huszar D; Pan Y J Neuroimmunol; 2002 Apr; 125(1-2):59-65. PubMed ID: 11960641 [TBL] [Abstract][Full Text] [Related]